NK cell activation: Distinct stimulatory pathways counterbalancing inhibitory signals

Human Immunology

Volumn 61, Issue 1, 2000, Pages 18-27

  Bakker, Alexander B H ^a   Wu, Jun ^a   Phillips, Joseph H ^a   Lanier, Lewis L ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

2B4; DAP10; DAP12; NK cells

Indexed keywords

CELL ADHESION MOLECULE; LYMPHOCYTE ANTIGEN RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PHOSPHOTYROSINE;

ARTICLE; CELL ACTIVATION; CELL FUNCTION; EFFECTOR CELL; HUMAN; HUMAN CELL; IMMUNE SYSTEM; NATURAL KILLER CELL; NEGATIVE FEEDBACK; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICE; RECEPTORS, IMMUNOLOGIC;

EID: 0033957191     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(99)00160-3     Document Type: Article

References (109)

1. Scott P., Trinchieri G. The role of natural killer cells in host-parasite interactions. Curr Opin Immunol. 7:1995;34.
2. Unanue E.R. Inter-relationship among macrophages, natural killer cells and neutrophils in early stages of Listeria resistance. Curr Opin Immunol. 9:1997;35.
3. Scharton-Kersten T.M., Sher A. Role of natural killer cells in innate resistance to protozoan infections. Curr Opin Immunol. 9:1997;44.
4. Biron C.A., Nguyen K.B., Pien G.C., Cousens L.P., Salazar-Mather T.P. Natural killer cells in antiviral defense function and regulation by innate cytokines . Annu Rev Immunol. 17:1999;189.
5. Lanier L.L., Cwirla S., Phillips J.H. Genomic organization of T cell γ genes in human peripheral blood natural killer cells. J Immunol. 137:1986;3375.
6. Lanier L.L., Cwirla S., Federspiel N., Phillips J.H. Human natural killer cells isolated from peripheral blood do not rearrange T cell antigen receptor β chain genes. J Exp Med. 163:1986;209.
7. Loh E.Y., Cwirla S., Serafini A.T., Phillips J.H., Lanier L.L. Human T-cell receptor δ chain genomic organization, diversity, and expression in populations of cells . Proc Natl Acad Sci USA. 85:1988;9714.
8. Karre K., Ljunggren H.G., Piontek G., Kiessling R. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defense strategy. Nature. 319:1986;675.
9. Ljunggren H.-G., Karre K. In search of the 'missing self' MHC molecules and NK cell recognition . Immunol Today. 11:1990;237.
10. Lanier L.L. NK cell receptors. Annu Rev Immunol. 16:1998;359.
11. Yokoyama W.M. Natural killer cell receptors. Curr Opin Immunol. 10:1998;298.
12. Long E.O. Regulation of immune responses through inhibitory receptors. Annu Rev Immunol. 17:1999;875.
13. Lopez-Botet M., Bellon T. Natural killer cell activation and inhibition by receptors for MHC class I. Curr Opin Immunol. 11:1999;301.
14. Hersey P., Bolhuis R. 'Nonspecific' MHC-unrestricted killer cells and their receptors. Immunol Today. 8:1987;233.
15. Siliciano R.F., Pratt J.C., Schmidt R.E., Ritz J., Reinherz E.L. Activation of cytolytic T lymphocyte and natural killer cell function through the T11 sheep erythrocyte binding protein. Nature. 317:1985;428.
16. Timonen T., Patarroyo M., Gahmberg C.G. CD11a-c/CD18 and GP84 (LB-2) adhesion molecules on human large granular lymphocytes and their participation in natural killing. J Immunol. 141:1988;1041.
17. Lanier L.L., Buck D.W., Rhodes L., Ding A., Evans E., Barney C., Phillips J.H. Interleukin 2 activation of natural killer cells rapidly induces the expression and phosphorylation of the Leu-23 activation antigen. J Exp Med. 167:1988;1572.
18. Robertson M.J., Caligiuri M.A., Manley T.J., Levine H., Ritz J. Human natural killer cell adhesion molecules differential expression after activation and participation in cytolysis . J Immunol. 145:1990;3194.
19. Shibuya A., Campbell D., Hannum C., Yssel H., Franz-Bacon K., McClanahan T., Kitamura T., Nicholl J., Sutherland G.R., Lanier L.L., Phillips J.H. DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes. Immunity. 4:1996;573.
20. Azuma M., Cayabyab M., Buck D., Phillips J.H., Lanier L.L. Involvement of CD28 in major histocompatibility complex-unrestricted cytotoxicity mediated by a human NK leukemia cell line. J Immunol. 149:1992;1115.
21. Nandi D., Gross J.A., Allison J.P. CD28-mediated costimulation is necessary for optimal proliferation of murine NK cells. J Immunol. 152:1994;3361.
22. Daeron M. Fc receptor biology. Annu Rev Immunol. 15:1997;203.
23. Perussia B., Trinchieri G., Jackson A., Warner N.L., Faust J., Rumpold H., Kraft D., Lanier L.L. The Fc receptor for IgG on human natural killer cells phenotypic, functional, and comparative studies with monoclonal antibodies . J Immunol. 133:1984;180.
24. 2+ in FcγR (CD16)-induced transcription and expression of lymphokine genes . J Exp Med. 169:1989;549.
25. Anegon I., Cuturi M.C., Trinchieri G., Perussia B. Interaction of Fc receptor (CD16) ligands induces transcription of interleukin 2 receptors (CD25) and lymphokine genes and expression of their products in human natural killer cells. J Exp Med. 167:1988;452.
26. Ravetch J.V., Perussia B. Alternative membrane forms of FcγRIII (CD16) on human natural killer cells and neutrophils cell type-specific expression of two genes that differ in single nucleotide substitutions . J Exp Med. 170:1989;481.
27. Lanier L.L., Yu G., Phillips J.H. Co-association of CD3ζ with a receptor (CD16) for IgG Fc on human natural killer cells. Nature. 342:1989;803.
28. O'Shea J., Weissman A.M., Kennedy I.C.S., Ortaldo J.R. Engagement of the natural killer cell IgG Fc receptor results in tyrosine phosphorylation of the ζ chain. Proc Natl Acad Sci USA. 88:1991;350.
29. Vivier E., da Silva A.J., Ackerly M., Levine H., Rudd C.E., Anderson P. Association of a 70-kDa tyrosine phosphoprotein with the CD16:ζ;γ complex expressed in human natural killer cells. Eur J Immunol. 23:1993;1872.
30. Ryan J.C., Seaman W.E. Divergent functions of lectin-like receptors on NK cells. Immunol Rev. 155:1997;79.
31. Arase N., Arase H., Park S.Y., Ohno H., Ra C., Saito T. Association with FcRγ is essential for activation signal through NKR-P1 (CD161) in natural killer (NK) cells and NK1 1+ T cells . J Exp Med. 186:1997;1957.
32. Kung S.K., Su R.C., Shannon J., Miller R.G. The NKR-P1B gene product is an inhibitory receptor on SJL/J NK cells. J Immunol. 162:1999;5876.
33. Carlyle J.R., Martin A., Mehra A., Attisano L., Tsui F.W., Zuniga-Pflucker J.C. Mouse NKR-P1B, a novel NK1.1 antigen with inhibitory function. J Immunol. 162:1999;5917.
34. Lanier L.L., Chang C., Phillips J.H. Human NKR P1A a disulfide linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes . J Immunol. 153:1994;2417.
35. Poggi A., Costa P., Morelli L., Cantoni C., Pella N., Spada F., Biassoni R., Nanni L., Revello V., Tomasello E., Mingari M.C., Moretta A., Moretta L. Expression of human NKRP1A by CD34+ immature thymocytes NKRP1A-mediated regulation of proliferation and cytolytic activity . Eur J Immunol. 26:1996;1266.
36. Garni-Wagner B.A., Purohit A., Mathew P.A., Bennett M., Kumar K. A novel function-associated molecule related to non-MHC-restricted cytotoxicity mediated by activated natural killer cells and T cells. J Immunol. 151:1993;60.
37. Mathew P.A., Garni-Wagner B.A., Land K., Takashima A., Stoneman E., Bennett M., Kumar V. Cloning and characterization of the 2B4 gene encoding a molecule associated with non-MHC-restricted killing mediated by activated natural killer cells and T cells. J Immunol. 151:1993;5328.
38. Tangye S.G., Lazetic S., Woollatt E., Sutherland G.R., Lanier L.L., Phillips J.H. Human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP. J Immunol. 162:1999;6981.
39. Nakajima H., Cella M., Langen H., Friedlein A., Colonna M. Activating interactions in human NK cell recognition the role of 2B4-CD48 . Eur J Immunol. 29:1999;1676.
40. Valiante N.M., Trinchieri G. Identification of a novel signal transduction surface molecule on human cytotoxic lymphocytes. J Exp Med. 178:1993;1397.
41. Cocks B.G., Chang C.-C.J., Carballido J.M., Yssel H., de Vries J.E., Aversa G. A novel receptor involved in T-cell activation. Nature. 376:1995;260.
42. Sayos J., Wu C., Morra M., Wang N., Zhang X., Allen D., van Schaik S., Notarangelo L., Geha R., Roncarolo M.G., Oettgen H., De Vries J.E., Aversa G., Terhorst C. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature. 395:1998;462.
43. Schatzle J.D., Sheu S., Stepp S.E., Mathew P.A., Bennett M., Kumar V. Characterization of inhibitory and stimulatory forms of the murine natural killer cell receptor 2B4. Proc Natl Acad Sci USA. 96:1999;3870.
44. Brown M.H., Boles K., Anton van der Merwe P., Kumar V., Mathew P.A., Barclay N.A. 2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48. J Exp Med. 188:1998;2083.
45. Latchman Y., McKay P.F., Reiser H. Identification of the 2B4 molecule as a counter-receptor for CD48. J Immunol. 161:1998;5809.
46. Kato K., Koyanagi M., Okada H., Takanashi T., Wong Y.W., Williams A.F., Okumura K., Yagita H. CD48 is a counter-receptor for mouse CD2 and is involved in T cell activation. J Exp Med. 176:1992;1241.
47. Gonzalez-Cabrero J., Wise C.J., Latchman Y., Freeman G.J., Sharpe A.H., Reiser H. CD48-deficient mice have a pronounced defect in CD4+ T cell activation. Proc Nat Acad Sci USA. 96:1999;1019.
48. Killeen N., Stuart S.G., Littman D.R. Development and function of T cells in mice with a disrupted CD2 gene. EMBO J. 11:1992;4329.
49. Brown M.G., Fulmek S., Matsumoto K., Cho R., Lyons P.A., Levy E.R., Scalzo A.A., Yokoyama W.M. A 2-Mb YAC contig and physical map of the natural killer gene complex on mouse chromosome 6. Genomics. 42:1997;16.
50. Westgaard I.H., Berg S.F., Orstavik S., Fossum S., Dissen E. Identification of a human member of the Ly-49 multigene family. Eur J Immunol. 28:1998;1839.
51. Barten R., Trowsdale J. The human Ly-49L gene. Immunogenetics. 49:1999;731.
52. Olcese L., Lang P., Vely F., Cambiaggi A., Marguet D., Blery M., Hippen K.L., Biassoni R., Moretta A., Moretta L., Cambier J.C., Vivier E. Human and mouse killer-cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases. J Immunol. 156:1996;4531.
53. Nakamura M.C., Niemi E.C., Fisher M.J., Shultz L.D., Seaman W.E., Ryan J.C. Mouse Ly49A interrupts early signaling events in NK cell cytotoxicity and functionally associates with the SHP-1 tyrosine phosphatase. J Exp Med. 185:1997;673.
54. Lazetic S., Chang C., Houchins J.P., Lanier L.L., Phillips J.H. Human NK cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. J Immunol. 157:1996;4741.
55. Carretero M., Cantoni C., Bellon T., Bottino C., Biassoni R., Rodriguez A., Perez-Villar J.J., Moretta L., Moretta A., Lopez-Botet M. The CD94 and NKG2-A C type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules. Eur J Immunol. 27:1997;563.
56. Brooks A.G., Posch P.E., Scorzelli C.J., Borrego F., Coligan J.E. NKG2A complexed with CD94 defines a novel inhibitory NK cell receptor. J Exp Med. 185:1997;795.
57. Le Drean E., Vely F., Olcese L., Cambiaggi A., Guia S., Krystal G., Gervois N., Moretta A., Jotereau F., Vivier E. Inhibition of antigen-induced T cell response and antibody-induced NK cell cytotoxicity by NKG2A association of NKG2A with SHP-1 and SHP-2 protein-tyrosine phosphatase . Eur J Immunol. 28:1998;264.
58. Braud V.M., Allan D.S.J., O'Callaghan C.A., Soderstrom K., D'Andrea A., Ogg G.S., Lazetic S., Young N.T., Bell J.I., Phillips J.H., Lanier L.L., McMichael A.J. HLA-E binds to natural killer cell receptors CD94/NKG2A, B, and C. Nature. 391:1998;795.
59. Borrego F., Ulbrecht M., Weiss E.H., Coligan J.E., Brooks A.G. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J Exp Med. 187:1998;813.
60. Lee N., Llano M., Carretero M., Ishitani A., Navarro F., Lopez-Botet M., Geraghty D.E. HLA-E is a major ligand for the NK inhibitory receptor CD94/NKG2A. Proc Natl Acad Sci USA. 95:1998;5199.
61. Aldrich C.J., DeCloux A., Woods A.S., Cotter R.J., Soloski M.J., Forman J. Identification of a TAP-dependent leader peptide recognized by alloreactive T cells specific for a class Ib antigen. Cell. 79:1994;649.
62. Vance R.E., Kraft J.R., Altman J.D., Jensen P.E., Raulet D.H. Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b). J Exp Med. 188:1998;1841.
63. Cantoni C., Verdiani S., Falco M., Pessino A., Conte R., Pende D., Ponte M., Moretta L., Biassoni R. p49, a putative HLA class I-specific inhibitory NK receptor belonging to the immunoglobulin superfamily. Eur J Immunol. 28:1998;1980.
64. Rajagopalan S., Long E.O. An HLA-G-specific receptor expressed on all natural killer cells. J Exp Med. 189:1999;1093.
65. Samaridis J., Colonna M. Cloning of novel immunoglobulin superfamily receptors expressed on human myeloid and lymphoid cells structural evidence for a new stimulatory and inhibitory pathways . Eur J Immunol. 27:1997;660.
66. Wagtmann N., Rojo S., Eichler E., Mohrenweiser H., Long E.O. A new human gene complex encodes the killer cell inhibitory receptors and a related family of monocyte/macrophage receptors. Cur Biol. 7:1997;615.
67. Arm J.P., Nwankwo C., Austen K.F. Molecular identification of a novel family of human Ig superfamily members that possess immunoreceptor tyrosine-based inhibition motifs and homology to the mouse gp49B1 inhibitory receptor. J Immunol. 159:1997;2342.
68. Cosman D., Fanger N., Borges L., Kibin M., Chin W., Peterson L., Hsu M.-L. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity. 7:1997;273.
69. Colonna M., Navarro F., Bellon T., Llano M., Garcia P., Samaridis J., Angman L., Cella M., Lopez-Botet M. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med. 186:1997;1809.
70. Colonna M., Samaridis J., Cella M., Angman L., Allen R.L., O'Callaghan C.A., Dunbar R., Ogg G.S., Cerundolo V., Rollick A. Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. J Immunol. 160:1998;3096.
71. Navarro F., Llano M., Bellon T., Colonna M., Geraghty D.E., Lopez-Botet M. The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells. Eur J Immunol. 29:1999;277.
72. Borges L., Hsu M.-L., Fanger N., Kubin M., Cosman D. A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules. J Immunol. 159:1997;5192.
73. Kubagawa H., Burrows P.D., Cooper M.D. A novel pair of immunoglobulin-like receptors expressed by B cells and myeloid cells. Proc Natl Acad Sci USA. 94:1997;5261.
74. Hayami K., Fukuta D., Nishikawa Y., Yamashita Y., Inui M., Ohyama Y., Hikida M., Ohmori H., Takai T. Molecular cloning of a novel murine cell-surface glycoprotein homologous to killer cell inhibitory receptors. J Biol Chem. 272:1997;7320.
75. Dupont B., Selvakumar A., Steffens U. The killer cell inhibitory receptor genomic region on human chromosome 19q13.4. Tiss Antigens. 49:1997;557.
76. Maeda A., Kuorsaki M., Kurosaki T. Paired immunoglobulin-like receptor (PIR)-A is involved in activating mast cells through its association with Fc receptor γ chain. J Exp Med. 188:1998;991.
77. Yamashita Y., Ono M., Takai T. Inhibitory and stimulatory functions of paired Ig-like receptor (PIR) family in RBL-2H3 cells. J Immunol. 161:1998;4042.
78. Nakajima H., Samaridis J., Angman L., Colonna M. Human myeloid cells express an activating ILT receptor (ILT1) that associates with Fc receptor γ-chain. J Immunol. 162:1999;5.
79. Biassoni R., Cantoni C., Falco M., Verdiani S., Bottino C., Vitale M., Conte R., Poggi A., Moretta A., Moretta L. The human leukocyte antigen (HLA)-C specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions. J Exp Med. 183:1996;645.
80. Houchins J.P., Lanier L.L., Niemi E., Phillips J.H., Ryan J.C. Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C. J Immunol. 158:1997;3603.
81. Mason L.H., Anderson S.K., Yokoyama W.M., Smith H.R.C., Winkler-Pickett R., Ortaldo J.R. The Ly-49D receptor activates murine natural killer cells. J Exp Med. 184:1996;2119.
82. Lanier L.L., Corliss B.C., Wu J., Leong C., Phillips J.H. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature. 391:1998;703.
83. Olcese L., Cambiaggi A., Semenzato G., Bottino C., Moretta A., Vivier E. Human killer cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cells. J Immunol. 158:1997;5083.
84. Campbell K.S., Cella M., Carretero M., Lopez-Botet M., Colonna M. Signaling through human killer cell activating receptors triggers tyrosine phosphorylation of an associated protein complex. Eur J Immunol. 28:1998;599.
85. McVicar D.W., Taylor L.S., Gosselin P., Willette-Brown J., Mikhael A.I., Geahlen R.L., Nakamura M.C., Linnemeyer P., Seaman W.E., Anderson S.K., Ortaldo J.R., Mason L.H. DAP12-mediated signal transduction in natural killer cells A dominant role for the syk protein-tyrosine kinase . J Biol Chem. 273:1998;32934.
86. Mason L.H., Willette-Brown J., Anderson S.K., Gosselin P., Shores E.W., Love P.E., Ortaldo J.R., McVicar D.W. Characterization of an associated 16 kDA tyrosine phosphoprotein require for Ly-49D signal transduction. J Immunol. 160:1998;4148.
87. Smith K.M., Wu J., Bakker A.B.H., Phillips J.H., Lanier L.L. Ly49D and Ly49H associate with mouse DAP12 and form activating receptors. J Immunol. 161:1998;7.
88. Lanier L.L., Corliss B., Wu J., Phillips J.H. Association of DAP12 with activating CD94/NKG2C NK cell receptors. Immunity. 8:1998;693.
89. Biassoni R., Pessino A., Malaspina A., Cantoni C., Bottino C., Sivori S., Moretta L., Moretta A. Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA-Cw4 molecules. Eur J Immunol. 27:1997;3095.
90. Winter C.C., Gumperz J.E., Parham P., Long E.O., Wagtmann N. Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition. J Immunol. 161:1998;571.
91. Valiante N.M., Uhrberg M., Shilling H.G., Lienert-Weidenbach K., Arnett K.L., D'Andrea A., Phillips J.H., Lanier L.L., Parham P. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity. 7:1997;739.
92. Uhrberg M., Valiante N.M., Shum B.P., Shilling H.G., Lienert-Weidenbach K., Corliss B., Tyan D., Lanier L.L., Parham P. Human diversity in killer cell inhibitory receptor (KIR) genes. Immunity. 7:1997;753.
93. Cantoni C., Biassoni R., Pende D., Sivori S., Accame L., Pareti L., Semenzato G., Moretta L., Moretta A., Bottino C. The activating form of CD94 receptor complex CD94 covalently associated with the Kp39 protein that represents the product of the NKG2-C gene . Eur J Immunol. 28:1998;327.
94. Marincola F.M., Shamamian P., Alexander R.B., Gnarra J.R., Turetskaya R.L., Nedospasov S.A., Simonis T.B., Taubenberger J.K., Yannelli J., Mixon A., et al. Loss of HLA haplotype and B locus down-regulation in melanoma cell lines. J Immunol. 153:1994;1225.
95. Cohen G.B., Gandhi R.T., Davis D.M., Mandelboim O., Chem B.K., Strominger J.L., Baltimore D. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity. 10:1999;661.
96. Vitale M., Bottino C., Sivori S., Sanseverino L., Castriconi R., Marcenaro E., Augugliaro R., Moretta L., Moretta A. NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. J Exp Med. 187:1998;2065.
97. Cantoni C., Bottino C., Vitale M., Pessino A., Augugliaro R., Malaspina A., Parolini S., Moretta L., Moretta A., Biassoni R. NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily. J Exp Med. 189:1999;787.
98. Sivori S., Vitale M., Morelli L., Sanseverino L., Augugliaro R., Bottino C., Moretta L., Moretta A. p46, a novel natural killer cell-specific surface molecule that mediates cell activation. J Exp Med. 186:1997;1129.
99. Pessino A., Sivori S., Bottino C., Malaspina A., Morelli L., Moretta L., Biassoni R., Moretta A. Molecular cloning of NKp46 a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity . J Exp Med. 188:1998;953.
100. Sivori S., Pende D., Bottino C., Marcenaro E., Pessino A., Biassoni R., Moretta L., Moretta A. NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK ceils Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells . Eur J Immunol. 29:1999;1656.
101. Tomasello E., Olcese L., Vely F., Geourgeon C., Blery M., Moqrich A., Gautheret D., Djabali M., Mattei M.-G., Vivier E. Gene structure, expression pattern, and biological activity of mouse killer cell activating receptor-associated protein (KARAP)/DAP-12. J Biol Chem. 273:1998;34115.
102. Bakker A.B.H., Baker E., Sutherland G.R., Phillips J.H., Lanier L.L. Myeloid DAP12-associating Lectin (MDL)-1 is a novel cell surface receptor involved in the activation of myeloid cells. Proc Natl Acad Sci USA. 96:1999;9792.
103. Wu J., Song Y., Bakker A.B.H., Bauer S., Spies T., Lanier L.L., Phillips J.H. An activating immunoreceptor complex formed by NKG2D and DAP10. Science. 285:1999;730.
104. Songyang Z., Shoelson S.E., Chaudhuri M., Gish G., Pawson T., Haser W.G., King F., Roberts T., Ratnofsky S., Lechleider R.J., et al. SH2 domains recognize specific phosphopeptide sequences. Cell. 72:1993;767.
105. Houchins J.P., Yabe T., McSherry C., Bach F.H. DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells. J Exp Med. 173:1991;1017.
106. Bauer S., Groh V., Wu J., Steinle A., Phillips J.H., Lanier L.L., Spies T. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science. 285:1999;727.
107. Groh V., Bahram S., Bauer S., Herman A., Beauchamp M., Spies T. Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc Natl Acad Sci USA. 93:1996;12445.
108. Groh V., Steinle A., Bauer S., Spies T. Recognition of stress-induced MHC molecules by intestinal epithelial γδ T cells. Science. 279:1998;1737.
109. Groh V., Rhinehart R., Secrist H., Bauer S., Grabstein K.H., Spies T. Broad tumor-associated expression and recognition by tumor-derived gammadelta T cells of MICA and MICB. Proc Natl Acad Sci USA. 96:1999;6879.